News

In the first part of his Pharma Commerce video interview, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, discusses ...
| AI solutions in clinical trials are only as good as the data they process. With a focus on quality, AI can be harnessed to ...
An international group of psychiatrists, patient associations, and pharmaceutical companies has unveiled plans to ...
Ascletis Pharma begins patient dosing in US phase I study of ASC50, an oral small molecule IL-17 inhibitor for psoriasis treatment: Hong Kong Thursday, June 19, 2025, 14:00 Hrs [I ...